SLC13A2 and nephrolithiasis: This study investigated the presence of the rs11568476 (V477M) polymorphism in the SLC13A2 gene in Turkish patients with calcium-containing nephrolithiasis, particularly focusing on its relationship with hypocitraturia, a known and common metabolic risk factor for kidney stone formation.